Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkins Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05844956
What this trial is testing

DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1)

Who this might be right for
Lymphoma, Non-Hodgkin
Dizal Pharmaceuticals 17
Testing effectiveness (Phase 2)Study completedNCT03364231
What this trial is testing

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Marginal Zone LymphomaWaldenstrom MacroglobulinemiaNon Follicular Indolent Non-Hodgkin Lymphoma
TG Therapeutics, Inc. 21
Testing effectiveness (Phase 2)UnknownNCT02836639
What this trial is testing

BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Pusan National University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01926639
What this trial is testing

Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Oslo University Hospital 14
Testing effectiveness (Phase 2)Ended earlyNCT00365274
What this trial is testing

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT00156013
What this trial is testing

Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Lymphoma, B-CellLymphoma, Non-Hodgkin
Oncology Specialists, S.C. 33
Testing effectiveness (Phase 2)Study completedNCT01007292
What this trial is testing

YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

Who this might be right for
Non-Hodgkin's Lymphoma
Astellas Pharma Inc 43
Early research (Phase 1)Looking for participantsNCT05780034
What this trial is testing

AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
Accutar Biotechnology Inc 60
Early research (Phase 1)Study completedNCT00006009
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Stanford University
Early research (Phase 1)Study completedNCT01567709
What this trial is testing

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more
National Cancer Institute (NCI) 34
Not applicableLooking for participantsNCT05518851
What this trial is testing

TreAtments and outComes in paTients With prImary CutAneous Lymphoma

Who this might be right for
Primary Cutaneous Lymphoma
Peking University First Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT00003572
What this trial is testing

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT01538472
What this trial is testing

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT00893477
What this trial is testing

GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 60
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00664144
What this trial is testing

Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma

Who this might be right for
Hyperuricemia
Sanofi 33
Early research (Phase 1)Study completedNCT00556699
What this trial is testing

SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Genentech, Inc. 22
Early research (Phase 1)UnknownNCT05005299
What this trial is testing

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2+3 more
Melbourne Health 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05025800
What this trial is testing

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
Aggressive B-Cell Non-Hodgkin LymphomaAnn Arbor Stage III Grade 2 Follicular LymphomaAnn Arbor Stage III Grade 3 Follicular Lymphoma+17 more
M.D. Anderson Cancer Center 47
Next Page